Similar to F3 and CREB3L1, the upregulation of ORM1 (by 174.684-fold) indicated that the progression of prostate cancer in LNCaP xenograft tumor might be driven by an inflammatory tumor microenvironment. This evidence concerns the gene CREB3L1 and neoplasm.